|Articles|October 1, 2005

Pharmaceutical Technology Europe

  • Pharmaceutical Technology Europe-10-01-2005
  • Volume 17
  • Issue 10

E-learning system for India

Regulatory and compliance requirements are frequently changing, and if that wasn't enough there is also numerous varying regulations across products, services and countries.

Regulatory and compliance requirements are frequently changing, and if that wasn't enough there is also numerous varying regulations across products, services and countries. This can be a difficult situation to fathom, especially for Indian biopharma companies who must deal with requirements at home as well as in their heavily regulated export markets. This is why Zenosis, a UK based company, has developed an e-learning and knowledge support system for regulatory compliance for the pharma sector. Learning is split into modules and is aimed at informing regulatory and non-regulatory personnel of current global regulatory and compliance affairs throughout the drug development pipeline. "The long and short of it is that Zenosis can help Indian life science companies get their products to the international market faster and stay there," commented Simon Burgess, CEO of Zenosis.

www.zenosis.com

Articles in this issue


Related to this article

FDA
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
Quality inspector walking through processing area with stainless tanks and tablet | Image Credit: ©Surachai -stock.adobe.com
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.